Clinical Trial: A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-236A and AD-236B

U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07730567) titled 'A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-236A and AD-236B' on July 23.

Brief Summary: To evaluate the pharmacokinetic interaction and the safety of AD-236A and AD-236B in healthy adult volunteers

Study Start Date: July 29

Study Type: INTERVENTIONAL

Condition: Hyperlipidemia Diabete Type 2

Intervention: DRUG: Treatment A(AD-236A)

AD-236A Oral Tablet

DRUG: Treatment B(AD-236B)

AD-236B Oral Tablet

DRUG: Treatment C(AD-236A+AD-236B)

AD-236A+AD-236B Oral Tablet

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Addpharma Inc.

Disclaimer: Curated by HT Syndication....